BioCardia

$3.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-1.22%) Today

-$0.24 (-5.94%) As of 1:04 PM UTC after-hours

Why Robinhood?

You can buy or sell BioCardia and other stocks, options, and ETFs commission-free!

About BCDA

BioCardia, Inc. operates as a clinical-stage regenerative medicine company. It develops novel therapeutics for cardiovascular diseases. The firm offers proprietary comprehensive biotherapeutic solutions for cardiovascular disease under the CardiAMP and CardiALLO brand. It operates in only one business segment, which is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The company was founded on January 12, 1994 and is headquartered in San Carlos, CA. The listed name for BCDA is BioCardia, Inc. Common Stock.

CEO

Peter Alan Altman

Employees

Headquarters

San Carlos, California

Founded

1994

Market Cap

68.41M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

509.70K

High Today

$4.09

Low Today

$3.75

Open Price

$3.82

Volume

390.04K

52 Week High

$8.60

52 Week Low

$1.91

Collections

BCDA Earnings

-$0.46

-$0.31

-$0.15

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 9, Pre-Market